⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XNCR News
Xencor, Inc.
Xenocor Appoints David McNally as Chief Executive Officer, Antony Watson to Chief Commercial Officer and David Van Ness to Chief Technology Officer
prnewswire.com
XNCR
CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
prnewswire.com
GILD
INCY
BIIB
NVS
AMGN
JNJ
ABBV
BMY
AZN
MRK
PFE
TGTX
XNCR
CABA
IMUX
ZNTL
GLPG
CLNN
AUTL
Form 8-K
sec.gov
XNCR
Form 8-K
sec.gov
XNCR
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast
businesswire.com
XNCR
Form 8-K
sec.gov
XNCR
Xencor Reports Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
XNCR
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization
prnewswire.com
XNCR
Xencor to Participate at Upcoming Investor Conferences
businesswire.com
XNCR
Primmune Therapeutics Appoints Chief Medical Officer and Executive Board Chair; Establishes Melanoma Clinical Study Advisory Board
globenewswire.com
ALGN
AZN
EXEL
VRTX
XNCR